Beitinjaneh, A., Gupta, S., Furqan, F., Baird, J., Weng, W., Jacobson, C., Kim, S., Feng, Z., Adedokun, B., Yan, J., Huang, Q., Hu, K., Best, T., Kloos, I., Lee, G., Hamadani, M., Pasquini, M., Locke, F. (2025). Real-world effectiveness and safety outcomes by age, comorbidities, and frailty among relapsed or refractory (R/R) Mantle Cell Lymphoma (MCL) patients treated with brexucabtagene autoleucel (brexu-cel). Blood. https://doi.org/10.1182/blood-2025-3606